CRP and diabetes mellitus: This observation indicates a greater global systemic inflammation status in diabetic patients, which has been previously suggested that may reflect the activity of the underlying atherosclerotic process [24], and it is concordant with several cross-sectional studies which have shown an increase of CRP levels in patients with diabetes [25-27].